Impact of a clinical pathway on cardiovascular risk in patients with diabetes.

María Concepción Fernández-PlanellesAntonio Palazón-BruMiriam Calvo-PérezAntonio Miguel Picó-AlfonsoVicente Francisco Gil-Guillén

Published in: Postgraduate medicine (2021)

The CP was of considerable benefit to metabolic control as well as control of dyslipidemia and obesity. Screening for diabetes also benefitted. The CP decreased the incidence of events, especially of angina pectoris.

Keyphrases

type diabetes
insulin resistance
metabolic syndrome
cardiovascular disease
weight loss
risk factors
coronary artery
glycemic control
percutaneous coronary intervention
weight gain
high fat diet induced
adipose tissue